3rd Quarter - Report
W STRATEGIES, LLC for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
P.L. 112-144, The Food and Drug Administration Safety and Innovation Act of 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Budget/Appropriations BUD
H.J.Res. 117: Continuing Appropriations Resolution for Fiscal Year 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.